You won't need a boatload of cash to build wealth with these top-tier companies.
Compare VRTX Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Vertex Pharmaceuticals
Both are biotech stocks with tremendous long-term opportunities.
There are good reasons behind analysts' optimism about these stocks.
Your returns would have been great until recently.
For those focused on the long game, the recent poor stock performances of Vertex Pharmaceuticals and Veeva Systems may present buying opportunities.
Their long-term prospects make these stocks great picks.
October is sometimes a scary month for investors. But you don't have anything to be afraid about buying these stocks.
A stock market that soured on biotech stocks in general is presenting some bargain opportunities.
Here are the top biotech picks from three Motley Fool contributors.
Analysts expect one of them could skyrocket more than 40% over the next 12 months.